Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold
Weight-loss drugs are taking the U.S. by storm. JPMorgan Chase (NYSE:JPM) is forecasting that the market for weight-loss medications could reach $100 billion in annual sales. The new class of drugs, known as “incretins,”...